|
Rationale for study
|
Y
|
Y
|
Y
|
Y
|
Y
|
Y
|
Y
|
|
Eligibility criteria
|
Y
|
P
|
Y
|
Y
|
Y
|
Y
|
Y
|
|
Recruitment method
|
N
|
N
|
P
|
P
|
Y
|
P
|
Y
|
|
Settings and location of study
|
P
|
P
|
Y
|
Y
|
P
|
P
|
P
|
|
Intervention
|
Y
|
P
|
Y
|
P
|
Y
|
P
|
Y
|
|
Objectives/hypotheses
|
P
|
P
|
N
|
P
|
P
|
Y
|
Y
|
|
Defined outcome measures
|
Y
|
P
|
N
|
N
|
P
|
Y
|
Y
|
|
Quality enhancers (e.g. multiple observations)
|
Y
| |
N
|
P
|
N
|
P
|
Y
|
|
Sample size determination
|
Y
|
N
|
N
|
N
|
P
|
Y
|
N
|
|
Randomisation
|
Alternately assigned
|
Y
|
Alternately assigned
|
Assigned by location
|
Not randomised
|
Y
|
Y
|
|
Randomisation sequence generation
|
Y
|
N
|
Y
|
Y
|
I
|
Y
|
Y
|
|
Allocation concealment
|
N
|
N
|
Y
|
N
|
N
|
N
|
N
|
|
Randomisation implementation methods
|
N
|
N
|
N
|
N
|
N
|
N
|
N
|
|
Blinding – participant
|
N
|
N
|
N
|
N
|
N
|
N
|
Y
|
|
Blinding – of those administering the intervention
|
N
|
N
|
N
|
N
|
N
|
P
|
N
|
|
Blinding – outcome/assessments
|
Y
|
N
|
Y
|
Y
|
N
|
Not all blinded
|
Not blinded
|
|
Statistical methods
|
Y
|
P
|
Y
|
Y
|
N
|
Y
|
Y
|
|
Flow of participants through each stage
|
Y
|
U
|
Y
|
N
|
P
|
P
|
Y
|
|
Recruitment and follow up dates
|
N
|
N
|
Y
|
N
|
N
|
P
|
N
|
|
Baseline demographics
|
Y
|
N
|
P
|
Y
|
Y
|
Y
|
Y
|
|
Numbers analysed (and ITT)
|
Y
|
U
|
P
|
U
|
Y
|
P
|
Y
|
|
Summary of Results
|
P
|
P
|
P
|
Y
|
P
|
Y
|
Y
|
|
Estimated effect sizes
|
N
|
P
|
N
|
N
|
N
|
N
|
N
|
|
Precision
|
N
|
N
|
N
|
Y
|
N
|
Y
|
N
|
|
Results for each outcome
|
Y
|
Y
|
Y
|
Y
|
P
|
Y
|
Y
|
|
Ancillary analyses
|
P
|
N
|
I
|
N
|
N
|
N
|
N
|
|
Adverse events
|
P
|
P
|
Y
|
N
|
P
|
N
|
N
|
|
Interpretation
|
P
|
P
|
P
|
P
|
N
|
N
|
P
|
|
Generalisability
|
P
|
P
|
Y
|
P
|
N
|
N
|
N
|
|
Results placed into context
|
P
|
P
|
P
|
P
|
P
|
P
|
P
|
|
Judged to be of sufficient quality for inclusion in explanatory meta-analyses?
|
N
|
N
|
N
|
N
|
N
|
Y
|
Y for Oxford hip score only
|
